IKT
Inhibikase Therapeutics, Inc.
There isn't enough reported data to score IKT yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IKT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
IKT's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
IKT PE Valuation
IKT has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
IKT Forward outlook
There aren't enough analyst estimates for IKT to show an outlook.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
IKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$2.68 | +$1.33 |
| Q2 2024 | -$2.89 | +$1.34 |
| Q1 2024 | -$3.34 | +$0.86 |
| Q4 2023 | -$3.57 | +$0.75 |
| Q3 2023 | -$4.01 | +$0.13 |
| Q2 2023 | -$4.23 | -$0.09 |
| Q1 2023 | -$4.20 | +$0.18 |
| Q4 2022 | -$4.32 | +$0.54 |
NVO has the stronger earnings trend. Trailing diluted EPS is down 115% for IKT versus NVO up 4.9%.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO's earnings per share have climbed steadily: $3.89 over the past year, up 4.9% from the year before, and higher year over year every quarter since late 2020.
IKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $1 | -100% |
| Q3 2023 | $79.6K | +991% |
| Q2 2023 | $116.4K | +1677% |
| Q1 2023 | $64.5K | +40% |
| Q4 2022 | $63.6K | +3170% |
| Q3 2022 | $7.3K | -98% |
| Q2 2022 | $6.6K | -100% |
| Q1 2022 | $46K | -97% |
IKT's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2023 | -440356600% | -440349780 points |
| Q3 2023 | -5993% | +55906 points |
| Q2 2023 | -5328% | +65489 points |
| Q1 2023 | -7308% | +2774 points |
| Q4 2022 | -6820% | +252515 points |
| Q3 2022 | -61900% | -60538 points |
| Q2 2022 | -70817% | -70624 points |
| Q1 2022 | -10081% | -9895 points |
IKT's operating margin was −440356600% last quarter, down 440349780 points from the same quarter a year ago, near the bottom of its range since 2019.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO's operating margin was 34% last quarter, down 9 points from the same quarter a year ago, near the bottom of its range since 2019.
IKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.4M | -$6.8M |
| Q2 2026 | -$12.4M | -$6.9M |
| Q1 2026 | -$12.1M | -$7.9M |
| Q4 2025 | -$7.5M | -$2.2M |
| Q3 2025 | -$10.6M | -$5.7M |
| Q1 2025 | -$4.1M | -$249.9K |
| Q4 2024 | -$5.3M | -$1.9M |
| Q3 2024 | -$4.9M | -$776K |
IKT has burned cash in almost every quarter: −$49M over the past year, against −$26M the year before.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over IKT on cash generation, producing positive trailing cash flow while its opponent burns cash.
IKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +22.4M shares |
| 1 year | +119% | +107M shares |
| 3 years | +4195% | +192M shares |
| 5 years | +14158% | +196M shares |
| Available history | +14344% | +196M shares |
IKT has 197M diluted shares, up 119% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over IKT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
IKT Net Leverage
IKT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
IKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.4 | Neutral |
| Stochastic | 6.5 | Oversold |
IKT's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
IKT PE vs Healthcare Sector
IKT has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
IKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.73 | 12% below |
| 20 week MA | $2.07 | 26% below |
| 50 week MA | $1.89 | 19% below |
| 100 week MA | $1.95 | 22% below |
| 200 week MA | $2.13 | 28% below |
IKT is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over IKT on trend strength, trading above more of its moving averages.
IKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $58.8 | $58.8 | 0% |
| 2021 | $58.8 | $9.42 | -84% |
| 2022 | $9.42 | $2.97 | -68% |
| 2023 | $2.97 | $1.27 | -57% |
| 2024 | $1.27 | $3.05 | +140% |
| 2025 | $3.05 | $2.00 | -34% |
| 2026 YTD | $2.00 | $1.53 | -24% |
IKT's yearly returns have swung widely, from +140% in 2024 to −84% in 2021. It's down 24% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over IKT on returns for 2026, with the stronger performance.